MDP Technicals trying to retest 3rd time support near 1.48 and upon successful bounce back, it can jump above 3.5 easily. Some thing can be sensed here. Eps positve. So hope positive. Take your own decision and study before any blind call
Long
Medexus Pharmaceuticals Inc
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.01 USD
2.17 M USD
104.70 M USD
29.66 M
About Medexus Pharmaceuticals Inc.
Sector
Industry
CEO
Kenneth d’Entremont
Website
Headquarters
Toronto
Founded
2003
IPO date
Mar 3, 2012
Identifiers
3
ISIN CA58410Q2036
Medexus Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products and treatment solutions focusing on therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. The firm products include IXINITY, Rasuvo, Metoject, Rupall, and Gleolan. The company was founded in 2003 and is headquartered in Toronto, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MEDXF is 2.10 USD — it has increased by 5.53% in the past 24 hours. Watch Medexus Pharmaceuticals Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Medexus Pharmaceuticals Inc stocks are traded under the ticker MEDXF.
MEDXF stock has risen by 1.69% compared to the previous week, the month change is a 0.29% rise, over the last year Medexus Pharmaceuticals Inc has showed a −3.67% decrease.
We've gathered analysts' opinions on Medexus Pharmaceuticals Inc future price: according to them, MEDXF price has a max estimate of 5.88 USD and a min estimate of 4.08 USD. Watch MEDXF chart and read a more detailed Medexus Pharmaceuticals Inc stock forecast: see what analysts think of Medexus Pharmaceuticals Inc and suggest that you do with its stocks.
MEDXF reached its all-time high on Feb 17, 2021 with the price of 7.76 USD, and its all-time low was 0.59 USD and was reached on Oct 3, 2022. View more price dynamics on MEDXF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MEDXF stock is 5.79% volatile and has beta coefficient of 1.41. Track Medexus Pharmaceuticals Inc stock price on the chart and check out the list of the most volatile stocks — is Medexus Pharmaceuticals Inc there?
Today Medexus Pharmaceuticals Inc has the market capitalization of 65.00 M, it has decreased by −0.75% over the last week.
Yes, you can track Medexus Pharmaceuticals Inc financials in yearly and quarterly reports right on TradingView.
Medexus Pharmaceuticals Inc is going to release the next earnings report on Jun 30, 2026. Keep track of upcoming events with our Earnings Calendar.
Medexus Pharmaceuticals Inc revenue for the last quarter amounts to 25.32 M USD, despite the estimated figure of 25.35 M USD. In the next quarter, revenue is expected to reach 25.57 M USD.
MEDXF net income for the last quarter is 81.23 K USD, while the quarter before that showed −311.46 K USD of net income which accounts for 126.08% change. Track more Medexus Pharmaceuticals Inc financial stats to get the full picture.
No, MEDXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 91 employees. See our rating of the largest employees — is Medexus Pharmaceuticals Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medexus Pharmaceuticals Inc EBITDA is 12.96 M USD, and current EBITDA margin is 16.80%. See more stats in Medexus Pharmaceuticals Inc financial statements.
Like other stocks, MEDXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medexus Pharmaceuticals Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medexus Pharmaceuticals Inc technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medexus Pharmaceuticals Inc stock shows the buy signal. See more of Medexus Pharmaceuticals Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.